CT三维重建技术指导肝门部胆管癌手术治疗临床意义探讨*

doi:10.3969/j.issn.1672-5069.2025.02.030

实用肝脏病杂志 ›› 2025, Vol. 28 ›› Issue (2): 278-281.doi: 10.3969/j.issn.1672-5069.2025.02.030

CT三维重建技术指导肝门部胆管癌手术治疗临床意义探讨^*

王鹤, 宋文月, 殷慧康, 尤琴琴

214000 江苏省无锡市解放军联勤保障部队第904医院影像科(王鹤,宋文月,殷慧康);南京医科大学附属南京医院影像科(尤琴琴)

收稿日期:2024-10-10 出版日期:2025-03-10 发布日期:2025-03-11
通讯作者: 殷慧康,E-mail:yhk048312@163.com
作者简介:王鹤,女,31岁,大学本科,住院医师。E-mail:18291009976@163.com
基金资助:
^*江苏省自然科学基金资助项目(编号:BK20201492)

CT three-dimensional reconstruction technology in guiding surgical resection of perihilar cholangiocarcinoma

Wang He, Song Wenyue, Yin Huikang, et al

Department of Radiology, 904th Hospital, Joint Logistics Support Force, Wuxi 214000, Jiangsu Province, China

Received:2024-10-10 Online:2025-03-10 Published:2025-03-11

摘要/Abstract

摘要： 目的评估CT三维重建技术指导肝门部胆管癌(PHCC)手术治疗的意义。方法 2019年6月～2024年6月我院收治的PHCC患者96例,均接受CT增强扫描并行三维重建Bismuth-Corlette分型。对可以行肿瘤切除的患者进行了肿瘤切除手术。结果 96例PHCC患者实际接受手术72例(75.0%);CT三维重建技术评估PHCC可切除性的敏感度为97.2%,特异度为54.2%,准确度为86.5%;与实际手术切除的组织病理学检查分型比,CT三维重建Bismuth-Corlette分型的准确率为91.6%;组织病理学检查显示本组实际手术切除的PHCC患者存在侵犯肝动脉、门静脉和肝静脉以及淋巴结转移分别为25例、28例、10例和15例;CT三维重建判别侵犯肝动脉、门静脉和肝静脉以及淋巴结转移的敏感度分别为92.0%、92.0%、90.0%和86.7%,特异度分别为89.4%、90.9%、96.8%和89.5%,准确度分别为90.3%、90.3%、95.8%和88.9%。结论 CT三维重建评估PHCC病灶浸润范围有助于提高术前诊断,对指导手术切除肿瘤具有很大的临床意义。

关键词: 肝门部胆管癌, CT三维重建, Bismuth-Corlette分型, 手术

Abstract: Objective The aim of this study was to investigate CT three-dimensional reconstruction technology in guiding surgical resection of perihilar cholangiocarcinoma(PHCC). Methods 96 patients with PHCC were encountered in our hospital between June 2019 and June 2024, and all underwent CT scan for three-dimensional reconstruction, and tumor resection thereafter. Results Seventy-two patients (75.0%)with PHCC in our serieshad actually had their tumor resected, and the sensitivity (Se), specificity (Sp) and accuracy (Ac) of CT three-dimensional reconstruction in evaluating the resectability of PHCC were 97.2%, 54.2% and 86.5%; based on histopathological classification, the Ac of CT three-dimensional reconstruction in judging Bismuth-Corlette classification was 91.6%; histopathological examination found artery, portal, venous invasion and lymph node metastasis in 25 cases, 28 cases, 10 cases and 15 cases out of the 72 patients with resected tumors; the Se were 92.0%, 92.0%, 90.0% and 86.7%, Sp were 89.4%, 90.9%, 96.8% and 89.5%, and Ac were 90.3%, 90.3%, 95.8% and 88.9% by CT three-dimensional reconstruction in judging artery, portal, venous invasion and lymph node metastasis. Conclusion Three-dimensional CT reconstruction in determining resectability of PHCC pre-operationally is helpful for clinicians making appropriate surgical decisions.

Key words: Perihilar cholangiocarcinoma, CT three-dimensional reconstruction, Bismuth-Corlette typing, Surgery

王鹤, 宋文月, 殷慧康, 尤琴琴. CT三维重建技术指导肝门部胆管癌手术治疗临床意义探讨^*[J]. 实用肝脏病杂志, 2025, 28(2): 278-281.

Wang He, Song Wenyue, Yin Huikang, et al. CT three-dimensional reconstruction technology in guiding surgical resection of perihilar cholangiocarcinoma[J]. Journal of Practical Hepatology, 2025, 28(2): 278-281.

参考文献

[1] Mao S, Shan Y, Yu X, et al. Development and validation of a novel preoperative clinical model for predicting lymph node metastasis in perihilar cholangiocarcinoma. BMC Cancer, 2024, 24(1):297.
[2] Mueller M, Breuer E, Mizuno T, et al. Perihilar cholangiocarcinoma - Novel benchmark values for surgical and oncological outcomes from 24 expert centers. Ann Surg, 2021, 274(5):780-788.
[3] Chebaro A, Jeddou H. Liver transplantation for perihilar cholangiocarcinoma is not a provocative idea. Hepatobiliary Surg Nutr, 2023, 12(2):232-234.
[4] Balci D, McCormack L. Perihilar cholangiocarcinoma: A difficult surgery in a difficultpatient where experience matters most. Surgery, 2021, 170(2):644-645.
[5] Wang Z, Zhang C, Jiao T, et al. Fully automatic segmentation and three-dimensional reconstruction of the liver in CT images. J Healthc Eng, 2018, 2018:6797102.
[6] Fang C, An J, Bruno A, etal. Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases. Hepatol Int, 2020, 14(4):437-453.
[7] Kuriyama N, Usui M, Gyoten K, et al. Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status. BMC Cancer, 2020, 20(1):405.
[8] Feng JW, Yang XH, Wu BQ, et al. Progress in diagnosis and surgical treatment of perihilar cholangiocarcinoma. Gastroenterol Hepatol, 2019, 42(4):271-279.
[9] Fang C, An J, Bruno A, et al. Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases. Hepatol Int, 2020, 14(4):437-453.
[10] Du H, Tan X, Cheng L, et al. Application and evaluation of a 64-slice CT three-dimensional fusion technique in the determination of the effective ablation margin after radiofrequency ablation of hepatocellular carcinoma. Comput Math Methods Med, 2022, 2022:6898233.
[11] 中华医学会外科学分会胆道外科学组, 解放军全军肝胆外科专业委员会. 肝门部胆管癌诊断和治疗指南(2013年版). 中华外科杂志, 2013, 51(10):865-871.
[12] Soares KC, Kamel I, Cosgrove DP, et al. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr, 2014, 3(1):18-34.
[13] Takahashi E, Fukasawa M, Sato T, et al. Biliary drainage strategy of unresectable malignant hilar strictures by computed tomography volumetry. World J Gastroenterol, 2015, 21(16):4946-4953.
[14] 王健东, 沈军, 周学平, 等. 提高Bismuth-Corlette Ⅲ型肝门部胆管癌根治性切除率及安全性的综合措施. 中华外科杂志, 2013, 51(7):596-599.
[15] 武盼盼, 徐蒙莱, 褚建华, 等. 应用CT三维重建技术判断肝门部胆管癌可切除性价值分析. 实用肝脏病杂志, 2020, 23(6):889-892.
[16] Fang CH, Tao HS, Yang J, et al. Impact of three-dimensional reconstruction technique in the operation planning of centrally located hepatocellular carcinoma. J Am Coll Surg, 2015, 220(1):28-37.
[17] Ni Q, Wang H, Liang X, et al. Successful parenchyma-sparing anatomical surgery by 3-dimensional reconstruction of hilar cholangiocarcinoma combined with anatomic variation. J Coll Physicians Surg Pak, 2016, 26(6 Suppl):S13-S15.
[18] 林骋, 曹利平. 三维重建技术指导肝门部胆管癌手术的应用体会. 中华普通外科学文献(电子版), 2018, 12(4):220-222.
[19] Zeng N, Tao H, Fang C, et al. Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type III hilar cholangiocarcinoma. World J Surg Oncol, 2016, 14(1):44.
[20] 杨骥, 黄强, 王成, 等. 计算机三维重建技术在指导肝门部胆管癌手术中的应用. 中华肝胆外科杂志, 2021, 27(2):114-117.

CT三维重建技术指导肝门部胆管癌手术治疗临床意义探讨^*

CT three-dimensional reconstruction technology in guiding surgical resection of perihilar cholangiocarcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	张树庚, 张少博, 朱泽斌, 栗雪峰, 蔡伟, 郭亚飞, 刘连新. Clavien-Dindo分级系统分析不同供肝类型肝移植患者术后早期并发症发生率比较研究^*[J]. 实用肝脏病杂志, 2023, 26(5): 738-741.
[2]	朱加猛, 范丽琴, 尹力, 吴柏华. 腹腔镜手术治疗巨大肝血管瘤患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(4): 564-567.
[3]	龚程, 田银生, 刘爽. 不同时间窗手术治疗原发性肝癌自发破裂出血患者2年生存率比较^*[J]. 实用肝脏病杂志, 2023, 26(2): 274-277.
[4]	尹秋实, 王学国, 宋奇锋. 左肝蒂阻断法行完全腹腔镜左半肝切除术与开腹手术治疗肝内外胆管结石患者效果比较^*[J]. 实用肝脏病杂志, 2023, 26(2): 282-285.
[5]	黄鹏, 孟凡斌, 张晓农, 于延铭. 3D模型指导下PTCSL微创治疗复杂性肝胆管结石患者效果研究^*[J]. 实用肝脏病杂志, 2022, 25(4): 595-598.
[6]	胡勇军, 汪磊, 刘宁, 晏华军. 间歇性全入肝血流阻断与区域性入肝血流阻断腹腔镜肝切除术治疗原发性肝癌患者术后恢复研究^*[J]. 实用肝脏病杂志, 2022, 25(3): 411-414.
[7]	贺伟, 刘贤国, 王刚, 卢建利, 叶智. 根治性手术治疗不同Child-Pugh分级的肝泡型包虫病患者疗效研究[J]. 实用肝脏病杂志, 2022, 25(3): 435-438.
[8]	海岳东, 王勇, 房秀霞, 郑俊全. 初期或后期经皮胆囊穿刺引流术与腹腔镜胆囊切除术序贯治疗急性胆囊炎患者疗效及安全性比较研究^*[J]. 实用肝脏病杂志, 2022, 25(1): 124-127.
[9]	俞士刚, 田佳, 吴铁, 樊书荣. 损伤控制性手术对创伤性肝破裂患者生存及相关应激指标的影响^*[J]. 实用肝脏病杂志, 2021, 24(6): 915-918.
[10]	孔庆利, 张志生, 梁志鹏. 肝动脉切除重建和门静脉切除重建治疗肝门部胆管癌患者效果研究[J]. 实用肝脏病杂志, 2021, 24(1): 127-130.
[11]	武盼盼, 徐蒙莱, 褚建华, 鲍亚星. 应用CT三维重建技术判断肝门部胆管癌可切除性价值分析^*[J]. 实用肝脏病杂志, 2020, 23(6): 889-892.
[12]	张静, 周新民. 应用重组人血小板生成素减少肝硬化患者术前血小板输注疗效初步研究^*[J]. 实用肝脏病杂志, 2020, 23(4): 552-555.
[13]	唐浩, 宋文渊, 曾凯. 两种手术方法对严重外伤性肝破裂患者生存率的影响^*[J]. 实用肝脏病杂志, 2020, 23(2): 280-283.
[14]	钱国武, 崔广莹, 宋展, 吕柯, 刘驰, 孙万日. 腹腔镜规则性肝段或肝叶切除治疗复杂性肝内胆管结石患者血浆皮质醇和外周血T淋巴细胞亚群的变化^*[J]. 实用肝脏病杂志, 2020, 23(1): 122-125.
[15]	刘文博, 张建业, 保积武, 刘震. 吲哚菁绿介导的近红外光检测技术在胆囊癌手术切除术中的应用^*[J]. 实用肝脏病杂志, 2019, 22(4): 573-576.